SEC Form 4 · accession 0001144204-15-003356
CAPRICOR THERAPEUTICS, INC. · CAPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua A Kazam
Director
Period of report
Jan 21, 2015
Accepted (ET)
Jan 22, 2015 · 7:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 21, 2015 | P | 7,096 | $3.523 | A | 38,084 | D | |
| Common Stock | holding | — | — | — | 12,276 | I | By Kazam Family Trust | |
| Common StockF2 | holding | — | — | — | 3,310 | I | By Spouse for Minor Child | |
| Common StockF3 | holding | — | — | — | 3,310 | I | By Kash Family Foundation |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person entered into a Share Purchase Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which the Reporting Person, on January 21, 2015, purchased an aggregate of 7,096 shares of the Issuer's common stock at a purchase price of $3.5230 per share for an aggregate purchase price of approximately US$25,000.
- F2Held by the Reporting Person's spouse as custodian for the benefit of their minor child under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
- F3The Reporting Person is the Co-Trustee of the Kash Family Foundation and he and the other co-trustee have the ability to vote and dispose of the shares held by the Foundation. However, the Reporting Person has no pecuniary interest in the shares held by the Foundation.